Kiniksa Pharmaceuticals (Kiniksa Pharmaceuticals) FCF Yield % : 1.61 (As of Apr. 30, 2024)

Kiniksa Pharmaceuticals FCF Yield % Chart

Kiniksa Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial															-2.28	-1.53	5.56	1.38	1.12

Competitive Comparison of Kiniksa Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Kiniksa Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kiniksa Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kiniksa Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Kiniksa Pharmaceuticals's FCF Yield % falls into.

Kiniksa Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Kiniksa Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

Kiniksa Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kiniksa Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Kiniksa Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Kiniksa Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kiniksa Pharmaceuticals (Kiniksa Pharmaceuticals) Business Description